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Marine bone marrow-deriv~ mast cells proliferate in response to interleukin 3. In addition to 6.biopterin, 7-biopterin was identified in th~¢ ~l ls  
by HPLC analysis of iodine ~!a.~ed e.,,.:racts and by alkaline pen~anganate oxidation to the 6- and 7,carbox~lic a ids. 7-Biopterin comprised 31.9 
(_+ 7.7)% of the total biopterin. It was absent in cells which were grown with of t.-p-chlorophenylalani~e, an inhibitor of try. ptophan 5-mono- 
osygenase. Both 6- and 7.biopterin were present in the cell as their tetrahydro forms. From these dala we conclude that 7-biopterin, incontrast 
to e.g. brain tissue, regularly occurs as a normal metabolite in primary mast cells and that it is generated during hydroxylation of tryptophan. 
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1. INTRODUCTION 
The de novo biosynthesis of H.~-6-biopterin begins 
with GTP. The first step is catalyzed by GTP-cyclohy- 
drolase I (EC 3.5.4.16) and results in the formation of 
dihydro-6-neopterin triphosphate. This intermediate is 
transformed into H4-6-biopterin by the sequential ac- 
tion of 6-pyruvoyl-H4pterin-s~nthase and sepiapterin 
reductase (EC 1.1.1.153) (el. [1]). Ha-6-bioptcrin is the 
natural and immediate electron donor for the hydroxyl- 
ation of the aromatic amino acids phenylalanine, tyro- 
sine, and tryptophan thus controlling the biosynthesis 
of the neurotransmitters pinephrine, dopamine, and 
serotonin as well as the catabolism of phenylalanine (for 
review see [2]). In the course of the hydroxylation reac- 
tion~ H4-6-biopterin s oxidized to the 4a-hydroxy H4bi- 
opterin (4a-carbinolamine) intermediate. Rapid forma- 
tion of quinonoid ihydro-6-biopterin is achieved by the 
catalytic action of 4a-carbinolamine d hydratase [3,4]. 
It is consensus view that the mechanisms of all of the 
aromatic amino acid hydroxylases are the same and 
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proceed via the 4a-carbinolamine intermediate of the 
reduced pteridine (cf. [2,5]). 
7-Biopterin was found to contribute 3.1 and 2.7% to 
the total biopterin found in human and mouse liver, 
respectively. Only trace, amounts of this isomer were 
found in the urine of normal individuals [6]. In patients 
with a new variant of H4-6-biopterin deficiency and 
evident hyperphenylalaninemia the urinary excretion of 
7-biopterin was increased and in some cases approached 
a 1:1 ratio as compared with 6-biopterin [6]. It had been 
strongly suggested [7] and then finally demonstrated [8]
that the in vitro formation of 7-biopterin occurs via a 
non-enzymatic re-arrangement of 4a-hydroxy H~biop- 
terin which results from an opening of the pyrazine ring 
and its recyclization. A genetic defect is assumed to 
cause increased 7-biopterin levels in patients with hy- 
perphenylalaninemia [7]. 
Recent evidence has shown that H4-6-biopterin is 
synthesized during multiplication and differentiation f
cells lacking neurotransmitter biosynthesis and phen- 
ylalanine degradation. This is the case during hemato- 
poiesis and cellular immune responses (of. [9]). Inter- 
feron-z, in cooperation with interleukin 2, was identi- 
fied as the factor which triggers neopterin and H4-6- 
biopterin synthesis in cells of the immune system 
[10,11]. To further address H4-6-biopterin lbrmation 
during cytokine-directed cell proliferation, bone mar- 
row-derived murine mast ceils were analyzed. The mul- 
tiplication of these primary mast cells is directed by 
interleukin 3 [12] and they produce serotonin [13]. In 
this study we demonstrate hat in contrast to brain tis- 
sue, H4-6-biopterin from the primary mast ceils is ac- 
cempanied by substantial mounts of the 7-isomer. 
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Fig. 1, Reverse-phase HPLC analysis of brain tissue and of mast cells extracts after acidic iodine oxidation (solvent I). A, marine brain tissue; B, 
marine bone marrow derived mast ceils. M' Monapterin which was added as standard prior to th~ oxidation step; bl, identified with 6-bioptcrin; 
b2, idcntilied with 7-bioptcrin; HM, 6-hydroxy- metlayl-ptcrin, 
2. MATERIALS AND METHODS 
2.1. Materials 
The following materials were obtained from the manufacturers in 
parentheses: Murine (m) recombinant (r) IL-3 (Baehem, Heidelberg), 
cell culture components (Bioehrom, Berlin), L-p-chlorophenylalanine 
(Sigma, MCmchen), HPLC columns (Bisehoff, Leonberg), 7-Biopterin 
was a gift from Dr, M. Viscontini (ZUrich); all other pteridines were 
from Schircks (.lena, Switzerland), 
2,2. Cell culture 
Homogenous populations ofmast ceils (>99% Alcian blue.positive) 
were obtained from bone marrow cultures of normal BALB/c mice as 
described previously [14], Primary mast cells (in vitro age: 3 to 4 weeks) 
were cultured at 5xl0 ~ cells.mL -~ in RPMI 1640 medium supplemented 
with 20% fetal calf serum, 2 ram t.-glutaminc, 10 -~ M alpha-thioglyc- 
erol, 100 U,ml "~ penicillin-streptomycin, and 10 ng.ml -~ raiL-3, After 
an incubation period of 40 h the mast cells were harvested and stored 
at -700C. L-p-chlorophcnylalaninc (5 raM) was added at to of this 
incubation period, when indicated. 
2.3. &erMine analysis 
Extracts from mast cells (1-2 × 10 ~) were prepared with 1 ml 1 N 
HCI; extracts from whole marine brain were prepared with 10 ml 1 
N HCI and 2 ml aliquots were processed further. H,~biopterin was 
oxidized by acidic iodine, deproteinized and pre.purlfied by cation- 
exchange as previously described [15], Modifications of the method 
have been detailed in [16]. For the quantification fdihydrobiopterin 
atiqaots of the acidic extracts were brought o pH 13, Oxidation with 
iodine (in 0.1 M NaOH) was followed by addition of 2 N HCI to 
change biopterin back in:o its cationic form [17]. The pre.eolumn and 
the separation column (250 × 4,6 ram) of the HPLC system consisted 
of Shandon Hypersil.ODS 5 jam, A Shlmadzu model RF 535 HPLC 
fluorescence detector was interfaced with a Shlmadzu C-R6A Chro- 
matopae analytical data system. The following pterins were used for 
reference: 6.biopterin, 7-biopterin; 6.neopterin, 7-ncopterln, mona- 
ptcrin, o-thrco.biopterin, 6-hydroxymethylpterin, 2-amino.4-oxo- 
pteridine, pterin.6.carboxaldehyde, pterin-6-carboxylic a id, and 
pterin-7.carboxylic acid, The following solvents were used: (I) 3% 
methanol, 1% aeetonitrile, pH 2,5 was adjusted with H.~PO~; (ll) 0.5% 
isopropanol, 0,5% methanol, pH 5.2 was adjusted with acetic acid; 
(lit) sodium acetate 50 mM, citric acid 5 raM, pH 5,2 was adjusted 
with NaOH; (IV) 5% methanol, sodium phosphate 100 raM° pH 3 was 
adjusted by H.~PO~, The flow rate was 1 ml.min -t at room temperature 
(20°C), For oxidation of pterins to thecorresponding carboxyLic acids 
(el. [18]) fractions 'bl' and "b2' were purified by HPLC in solvent I, 
concentrated by lyophilization and subjected to the alkaline perman- 
ganate method as described in [8], 
2,4, Determination of tO,ptophan S-mono-oxygenase 
Extracts from 2-3 × 107 mast cells were prepared and desalted as 
described in [11]. The enzyme was activated and then assayed as 
described in [19], The reaction product 5-hydroxytryptophan was sep- 
arated by reverse phase HPLC (mobile phase 0,01 M sodium acetate 
containing 15% methanol brought o pH 4,85 with acetic acid) and 
determined by its fluorescence { xcitation 285 nm, cmlssion 345 nm), 
3. RESULTS AND DISCUSSION 
The HPLC chromatograms of iodine-oxidized ex- 
tracts from routine brain tissue separated two pteridi- 
nes, 'bl' and a slower migrating fraction (Fig. IA). 
Comparison with the standard pterin mixture (see sec- 
tion 2) in solvents I, II, and Ill identified the latter as 
6-hydroxymethylpterin (data not shown). In contrast to 
brain tissue, HPLC chromatograms from primary mar- 
ine mast cells with solvent (I) (Fig. l B) and II (data not 
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Fig, 2, Reverse-phase HPLC of the pterin products formed after alka- 
line permanganate oaidation of'bl' and 'b2' in solvent IV, ¢I, identi- 
fied with 6-¢arbo~ylie-aeid (P6C); e2, identified with 7-earbo~ylie-acid 
(P7C); b, non-o~idized 6- and 7-biopterin (<0,1% of total), 7.Carboz- 
ylic.acid shows 9% of the relative fluorescence inlensity as compared 
to the 6.isomer. Fluorescent fraction~ close to the void volume were 
also found in lyophilized and mock o~idized solvent !. 
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Fig, 3. Reverse.phase H PLC analysis of mast cell extracts after acidic 
iodine oxidation (solvent 1). The cells were grown for 40 h with l-/7- 
chlorophenylalanine (5 raM) before harvest. For explanation of sym- 
bols see Fig. 1. 
shown) separated two major pterin fractions "bl' and 
'b2'. 6-Hydroxymethylpterin waseither absent or com- 
prised <10% of total pterins. 
The identification of 'bl' and 'b2' is addressed in 
more detail below. Advantage was taken of the fact that 
6.biopterin separates from 7-biopterin in solvents I and 
lI (Fig. 1~ standard). As expected, a comparison of 
HPLC chromatograms with the reference pterins 
showed that fraction 'bl' from brain tissue [17] and 
from the mast cells was identical with 6-biopterin. Frac- 
tion 'b2' which was only found in mast cells was identi- 
cal with 7-biopterin. It co-eluted with this isomer in 
solvent I (Fig. I B) and II (data not shown) which sepa- 
rate 6- from 7-biopterin. Its retention time was clearly 
different from the other pterins in at least one of the 
solvent systems I, II, or IIl. Alkaline iodine o~idation 
of the cell extract destroys H~biopterin, but oxidizes 
H,.biopterin to biopterin [17]. After this treatment nei- 
ther 6- nor 7-biopterin was detectable in the extracts of 
both mast cells and brain tissue. Therefore, it can be 
concluded that both fractions 'bl' and 'b2' are present 
as tetrahydro derivatives. 
Alkaline permanganate tr atment of 6- and 7-substi- 
tuted pterins oxidizes the side chains to the correspond- 
ing carboxylic acids (of. [18]) which were separated in 
HPLC buffer 1V [8] (Fig. 2). Ptefin 7-carboxylic acid is 
characterized bya marked reduction of its relative fluo- 
rescence intensity at 450 nm as compared to the f- 
isomer [8]. In our experiments, it displayed only 9% of 
that produced by pterin.6.carboxylic acid. HPLC sepa- 
ration of pterin 6- and 7.carboxylic acid (Fig. 2) and of 
the oxidation products obtained from the putative 6- 
and 7-bloptcrins of mast cells (Fig. 2) yielded identical 
clution profiles. Almost the same portion of total pterin 
carboxylic acid was recovered in form of the 7-isomer 
after permanganate treatment (30.5%) as previously 
had been present as putative 7.biopterin (32.3%). 
A greenish, instead of a blue fluorescence has been 
reported for ptcrin-7-carboxylic acid after separation by 
paper chromatography with 100 mM KH~.PO4 [20]. It 
lacks a discrete fluorescence emission maximum at 450 
nrn as is found for pterin-5-carboxylic acid but is char- 
acterized by an extended fluorescence emission band 
including longer wave lengths (H. Rembold, personal 
communication). This property was used as a further 
criterion for identifying the mast cell derived oxidation 
products as pterin-6- and 7-carboxylic acid. A change 
in the settings for fluorescence excitation from 350 to 
360 nm and for fluorescence emission from 450 to 475 
nm reduced the signal intensity of both the synthetic 
and the putative mast cell-derived pterin-7-earboxylic 
acid to only 34% and 36%, respectively, whereas the 
signal of pterin-6-carboxylic acid from both origins was 
reduced to only 95% and 85%, respectively. From these 
data we conclude that in primary mast cells H4-6-biop- 
terin is associated with its 7..isomer whereas in brain 
tissue only the 6-isomer is found. 
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Table 1 
6-Biopterin and 7-bioptcrln i marine interleukin 3-responsive mast 
cells. Primary mast cells derived from 4 different mouse bone marrow 
specimens were cultured in the presence ofmrl L-3 (10 ng.ml -*) for 40 
h, The tetrahydropterins were determined after acidic iodine oxidation 
of the cell extract 
Primary 6-biopterin 7-b iopter in %7-isomer of 
mast cells pmol/ 10 ~ cells pmol/10 ~cells total biopterin 
LD63 4,2 2,9 40,8 
LD70 2,5 0,8 24,2 
LD75 5.6 3.1 35,6 
LD76 4,6 1.7 27,0 
x _ S.D. 4.2 __. 1.3 2.1 _ 1.1 31,9 + 7,7 
Table I shows that H.,-7-biopterin averages 31,9 (+ 
7,7)% of the total H~biopterin in the mast cells. This 
demonstrates that substantial amounts of this isomer do 
originate not only under in vitro phenylalanine hydro- 
xylase assay conditions by omission of 4a-dehydratase 
[8] or in patients uffering from hyperphenylalaninemia 
who are supposed to be defective in this enzyme [6,7]. 
The data suggests that it rather originates also under in 
vivo conditions in primary mast cells during the course 
of  the tryptophan 5-mono-oxygenase (EC 1.14.16.4) re- 
action which shares the same mechanism with the other 
aromatic amino acid hydroxylases. 
The activity of  tryptophan 5-mono-oxygenase in the 
primary mast cells was 620 pmol.min-L.mg -~ protein 
before activation and 980 pmol,min-t,mg -~ protein 
after activation by DTT and Fe z*. p-Chlorophenylalan- 
ine inhibits phenylalanine 4-mono-oxygenase (EC 
1.14.16,1) and tryptophan 5-mono-oxygenase under in 
vitro as well as under in vivo conditions [19,21], Cultiva- 
tion of  the mast cells with this inhibitor caused absence 
of 7-biopterin (Fig. 3), 6-Biopterin was identified by 
co-elution with the standard (see Fig. 1), Its level in- 
creased to 6.7 (__.0.4) pmol/106 cells, thus compensating 
for the 7-isomer. It is therefore to be concluded that the 
7-isomer in primary mast cells originates from the tryp- 
tophan 5-mono-oxygenase reaction. 
The absence of  ?-biopterin in brain tissue, however, 
remains an open question. It is well documented that 
tryptophan 5-mono-oxygenase from a non-neuronal 
source such as the murine mast cell line P815 [19,23] or 
from intestinal mueosa [24] has different functional and 
regulatory properties. The non-neuronal enzyme needs 
to be activated and stabilized by DTT and Fe -~÷ prior 
to the assay [19,24]. Most likely, the enzymes from both 
sources represent distinct molecular entities [5]. The ab- 
sence of 7-biopterin in brain tissue raises the question 
whether neuronal and non-neuronal tryptophan 5- 
mono-oxygenases differently associate with 4a-dehy- 
dratase, thus affecting the recyclization of the H4-6- 
biopterin cofactor or whether the activity of the dehy. 
dratase in non-neuronal tissues is low. 
Acknow/edgcn~ents: We thank Dr. H. Rembold (Max Planck-lnstitut 
far Biochemic, Martinsried) for most valuable discussions and Dr. M. 
Viscontlnl for kindly providing us with 7.biopterin. The experiments 
were skill'ally assisted by Mrs. H. Broszeit and Mr. W. ROdl, The 
investigation was ~upported byGrant SCI' 0257.C from the Commis- 
sio~a of the European Communities and by the Bundesministerium far 
Forschung und Technologic (Project 01 KC89033). 
REFERENCES 
[1] Duch, D.S. and Smith, G.K. (1991)J. Nutr. Biochem, 2 411--423, 
[2] Kauflnan, S. and Fisher, D.B,, in: Oxygenases (O, Hayaishi, Ed,), 
Academic Press, New York, 1962, pp. 285-370. 
[3] Huang, C.Y. and Kaufman, S. (1973) J, Biol. Chum, 24B, 4242- 
425 I. 
[4] Lazarus, R.A., Benkovic, S.J. and Kaufman, S, (1983) J, Biol, 
Chem. 248, 4235--4241, 
[5] Kahn, D.M. and Lovenbcrg, W,, in: Folatcs and Pterins (R,L. 
Blakeley and St,J. Benkovic, Ed'Q Vol, 2, John Wiley and Sons, 
New York, 1984, pp, 353-382, 
[6] Curtius, H,Ch,, Matasovlc, A,, Schoedon, G., Kuster, Th., 
Gaibaud, P., Giudici, T, and Blau, 1'4. (1990) J. Biol. Chem. 265, 
3923-3930. 
[7] Curtius, H,Ch,, Adler, C,, Rebrin, 1., Heizmann, C, and Ghisla, 
S, (1990) Biochem. Biophys. Res. CoJa~mun. 172, 1060-1066, 
[8] Davis, M,D., Kaulhaan, S. and Milstien, Sh. (1991) Proc, Natl. 
Aead. Sei. USA 88, 385-389. 
[9] Ziegler, I. (1990) Mad. Res. Ray. 10, 95--114. 
[10] Huber, Ch., Batehetor, J.R., Fuel, s, D., Hausen, A., Lane, A,, 
Niederwieser, A. Reibne~ger, G. Swetley, P., Troppmair, J. and 
Waehter. H. (1984) J. Exp. Mad. 160, 310-316. 
[1 I] Ziegler, I., Sehott, K., Ltlbbert, M., Hoffmann, F., Schwulera, U.
and Bather, A. (1990) .I. Biol. Chem, 265, 17020-17030. 
[12] lhle, .I.N,, Keller, J.. Orozlan, S., Henderson, L.E,, Copeland, 
T.D., Fitch, F., Prystowsky, M.B., Goldwasscr, E,, Sehrader, 
.I.W,, Palaszynski, E., Dy, M, and Label, B, (1983) J. lmmunol. 
13 I, 282-287. 
[13] Schwartz, L.B. and Austen, K,F, (1984) Prog, Allergy 34, 271- 
321. 
[14] Htllmer, L., Sz/Sts, H,, Welle, M,, Van Snick, J,, Moeller, J, and 
DOrmer, P. (1989) Immunology 67, 408--413, 
[15] Zicg, ler, 1, (1985) J. Cell, Biochem, 28, 197-206, 
[16] Kerler, F,, Htllmer, L,, Zicgler, 1,, Katzenmeier, G.and iiacher, 
A. (1990) J, Cell. Physiol. 142, 268-271. 
[17] Fukushima, T. and Nixon, J,C. (1980) Analyt. Bioehem. 102, 
176-188, 
[18] Pfl¢idcrer, W,, in: Topics in Neurochemistry (M.B.H. Youdin, 
W, Lovenberg and K.P. Tipton, Eds.) Taylor and Francis, Lon- 
don, 1987, pp, 29-80. 
[19] Nakata, H. and Fujisawa, H. (1982) Eur. J. Bioehem. 124, 595- 
601. 
[20] Viscontini, M., Hadom, E, and Karrer, P. (19571 Helv. Chim. 
Acta 40, 579-585. 
[21] Miller, R.M., McClure, D. and Shiman, R. (1975)J. Biol. Chem. 
250, 1132-1140. 
[22] Chang, N., Kaufman, S. and Milstien, S. (1979) .1, Biol, Chem, 
254. 2665-2668. 
[23] Kuhn, D.M,, Meyer, M.A. and Lovenber8, W. (1980) Arch. 
Bioehem. Biophys. 199, 355-361. 
[24] Hasagawa, H., Yanagisawa, M., Inoue, F., Yanaihara, H. and 
lchiyama, A. (1987) Biochem, J 248, 501-509, 
150 
